Metastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenib

BACKGROUND: Renal cell carcinoma (RCC) is the most common type of kidney tumor with increasing incidence. Tyrosine Kinase Inhibitors (TKIs) are considered important treatment in the management of metastatic RCC. Some previous studies demonstrated that sorafenib treatment is associated with a signifi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Li, Zhi Yong, Fan, Xin Xiang, Wang, Yan Jun, Yao, Kai, Liu, Zhuo Wei, Pan, Wen Tao, Ye, Yun Lin, Yang, Ping, Huang, Yi Chuan, Wu, Zhi Ming, Zhou, Fang Jian
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085219/
https://ncbi.nlm.nih.gov/pubmed/27174916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9285
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars